<DOC>
	<DOCNO>NCT02804074</DOCNO>
	<brief_summary>MASTER study 4-year prospective , randomize , open-label , blinded-endpoint study ( PROBE ) compare 2 management strategy 1 ) office BP guide treatment , 2 ) 24-hour ABP guide treatment . Study objectives investigate whether management strategy base out-of-office BP ( Ambulatory BP monitoring ) versus management strategy base office BP measurement associate difference outcome , include cardiovascular renal intermediate end point one year ; cardiovascular event 4 year change number blood pressure-related variable throughout study . Patients followed-up first year focusing change leave ventricular mass index ( LVMI , co-primary endpoint ) Urinary albumin excretion ( UAE , albumin/creatinine ratio , co-primary end-point ) , whole 48 month period change LVMI UAE event include all-cause mortality , CV morbidity mortality , cerebral morbidity mortality.A total 1240 subject recruit 30 center , take account dropout rate 15 % ( 620 subject per randomization arm ) .</brief_summary>
	<brief_title>MASked-unconTrolled hypERtension Management Based Office BP Out-of-office ( Ambulatory ) BP Measurement</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Masked Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Male female subject Age 3580 year Masked uncontrolled ( treatment ) hypertension : office BP &lt; 140/90 mmHg , one follow situation : Ambulatory daytime BP &gt; 135/85 mmHg Ambulatory nighttime ABP &gt; 120/70 mmHg Ambulatory 24h ABP &gt; 130/80 mmHg eGFR â‰¥45 mL/min/1.73 m2 ( CKDEPI creatinine equation 2009 ) eGFR &lt; 45 mL/min/1.73 m2 ( CKDEPI creatinine equation 2009 ) , particular severe chronic renal failure define serum creatinine &gt; 250 umol/l ; Patients unstable clinical condition ; Known secondary hypertension ; Orthostatic hypotension ( SBP fall &gt; 20 mmHg standing ) ; Dementia ( clinical diagnosis ) ; Hepatic disease determine either AST ALT value &gt; 2 time upper limit normal History gastrointestinal surgery disorder could interfere drug absorption Known allergy contraindication one drug administer study History malignancy include leukaemia lymphoma ( basal cell skin cancer ) within last 5 year History clinically significant autoimmune disorder systemic lupus erythematosus . History drug alcohol abuse within last 5 year History noncompliance medical regimen and/or patient consider potentially unreliable Inability unwillingness give free inform consent Pregnancy plan pregnancy study period .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>